Healthtech and Medtech are growth sectors. The combination of AI and biotechnology is expanding start up innovation at unprecedented pace.
Start-up & Spin-off Consulting
Innovation generates the need to protect intellectual property, rights and patents from inception. Developing a service or product carries privacy and regulatory implications depending on the data used, the jurisdictions of deployment and the risk classification under MDR, IVDR or the AI Act. Setting up a new company is a project with demanding requirements for sound legal advice from the outset. We assist start-ups across the full lifecycle: corporate formation under ΙΚΕ (Law 4072/2012) or AE (Law 4548/2018), founders agreements, ESOP and SAFE/convertible loan structures, term sheets, shareholders agreements with VC standard provisions (preferred shares, ROFR, drag along, tag along, anti-dilution, liquidation preference, vesting), corporate governance, employment and consultancy agreements, customer and supplier contracts, GDPR compliance, regulatory pathway analysis under MDR/IVDR/AI Act and IP strategy. We also advise on academic and corporate spin offs, including IP carve outs from universities and research institutions, technology transfer agreements, license back arrangements, founder equity allocation, sponsored research agreements and the legal structuring of spin offs from research institutions under Law 4310/2014 on research, technological development and innovation. Our tailored approach includes tested partnerships with accounting and consulting firms with deep expertise in the start-up ecosystem. We support fundraising from pre seed to Series B with Greek and international investors and on Greek FDI screening under Law 4972/2022 where applicable.
